D. Andersen

发表

Plasmid‐encoded protein: The principal factor in the “metabolic burden” associated with recombinant bacteria

W. Bentley, D. Kompala, R. Davis, 1990, Biotechnology and bioengineering.

Plasmid-encoded protein: the principal factor in the "metabolic burden" associated with recombinant bacteria. Biotechnology Bioengineering, 1990.

Robert H. Davis, W. Bentley, D. Kompala, 2009, Biotechnology and bioengineering.

High‐level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple‐mutant (degP prc spr) host strain

John C Joly, Brad Snedecor, B. Snedecor, 2004, Biotechnology and bioengineering.

Increased in vivo effector function of human IgG4 isotype antibodies through afucosylation

Athena W Wong, R. Kelley, W. Phung, 2016, mAbs.

Controlling glycation of recombinant antibody in fed‐batch cell cultures

N. Vijayasankaran, B. Snedecor, J. Joly, 2011, Biotechnology and bioengineering.

Monosaccharide and oligosaccharide analysis of isoelectric focusing-separated and blotted granulocyte colony-stimulating factor glycoforms using high-pH anion-exchange chromatography with pulsed amperometric detection.

C. Goochee, D. Andersen, M. Weitzhandler, 1994, Glycobiology.

The effect of cell-culture conditions on the oligosaccharide structures of secreted glycoproteins.

C. Goochee, D. Andersen, Dana C. Andersen, 1994, Current opinion in biotechnology.

A strategy to accelerate protein production from a pool of clones in Chinese hamster ovary cells for toxicology studies

B. Snedecor, Michael W. Laird, J. Joly, 2017, Biotechnology progress.

Proteome analysis of antibody‐producing CHO cell lines with different metabolic profiles

E. Papoutsakis, D. Arnott, W. Miller, 2007, Biotechnology and bioengineering.

The Oligosaccharides of Glycoproteins: Bioprocess Factors Affecting Oligosaccharide Structure and their Effect on Glycoprotein Properties

C. Goochee, D. Andersen, M. Gramer, 1991, Bio/Technology.

The effect of ammonia on the O‐linked glycosylation of granulocyte colony‐stimulating factor produced by chinese hamster ovary cells

C. Goochee, D. Andersen, C F Goochee, 1995, Biotechnology and bioengineering.

A mathematical model of sialylation of N-linked oligosaccharides in the trans-Golgi network.

C. Goochee, D. Andersen, C F Goochee, 1997, Glycobiology.

Recombinant protein expression for therapeutic applications.

D. Andersen, L. Krummen, 2002, Current opinion in biotechnology.

Production technologies for monoclonal antibodies and their fragments.

D. Reilly, D. Andersen, Dorothea E Reilly, 2004, Current opinion in biotechnology.

Multiple cell culture factors can affect the glycosylation of Asn-184 in CHO-produced tissue-type plasminogen activator.

C. Hoy, D. Andersen, M. Gawlitzek, 2000, Biotechnology and bioengineering.

Analyzing mixtures of amino acids and carbohydrates using bi-modal integrated amperometric detection.

J. Cacia, N. Avdalović, D. Andersen, 1999, Journal of chromatography. B, Biomedical sciences and applications.

Evaluation of different primary recovery methods for E. coli-derived recombinant human growth hormone and compatibility with further down-stream purification.

D. Andersen, P. Lester, J. Persson, 2005, Biotechnology and bioengineering.

Metabolic oscillations in an E. coli fermentation.

B. Snedecor, T. Ryll, J. Swartz, 2001, Biotechnology and bioengineering.

Increased in vivo effector function of human IgG4 isotype antibodies through afucosylation

W. Phung, Jean-Michel Vernes, D. Andersen, 2016, mAbs.

Comparison of the Escherichia coli proteomes for recombinant human growth hormone producing and nonproducing fermentations

J. Nishihara, K. Champion, M. Vanderlaan, 2003, Proteomics.